{"schema_version":"1","generated_at":"2026-10-29T04:06:14.162Z","data_as_of":null,"url":"https://www.findmykol.com/kol/katherine-linder","json_url":"https://www.findmykol.com/kol/katherine-linder/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"katherine-linder","name":"Katherine Linder","credential":"MD","specialty":"Hematology","specialty_raw":"Hematology","therapeutic_area":"Hematology","therapeutic_areas":["Hematology"],"institution":"Hackensack University Medical Center","institution_url":"https://www.findmykol.com/institution/hackensack-university-medical-center","city":"Hackensack","state":"NJ","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1417358367","openalex":"A5047336278"},"summary":"Katherine Linder is a Hematology physician affiliated with Hackensack University Medical Center. OpenAlex indexes 24 publications with 279 citations (h-index 9).","overview":null,"focus":{"indications":[],"research_topics":["Hematology"]},"scholarship":{"works_count":24,"cited_by_count":279,"h_index":9,"latest_activity_year":2025,"source":"works"},"payments":{"company_count":27,"program_years":{"first":2021,"last":null},"rows_total":51,"shown":3,"withheld":48,"rows":[{"payer":"Takeda Pharmaceuticals U.S.A., Inc.","program_year":2025,"amount_usd":112.16,"payment_count":5,"source_url":"https://openpaymentsdata.cms.gov/search?query=1417358367"},{"payer":"Novartis Pharmaceuticals Corporation","program_year":2025,"amount_usd":112.11,"payment_count":5,"source_url":"https://openpaymentsdata.cms.gov/search?query=1417358367"},{"payer":"Geron Corporation","program_year":2025,"amount_usd":111.45,"payment_count":7,"source_url":"https://openpaymentsdata.cms.gov/search?query=1417358367"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1417358367","source":"payments"},"prescribing":{"data_year":2024,"areas_total":9,"areas_shown":3,"areas":[{"area":"Blood & clotting","share_pct":93.2,"classes_total":2,"classes":[{"class":"Erythropoiesis-stimulating Agent","setting":"administered","share_pct":93,"drugs":[{"name":"Epoetin alfa","share_pct":100}],"max_beneficiaries":26},{"class":"Thrombopoietin Receptor Agonist","setting":"prescribed","share_pct":0.2,"drugs":[{"name":"Promacta","share_pct":100}],"max_beneficiaries":null}]},{"area":"Cancer & immunology","share_pct":3.5,"classes_total":4,"classes":[{"class":"Kinase inhibitor","setting":"prescribed","share_pct":2,"drugs":[{"name":"Jakafi","share_pct":66.7},{"name":"Imatinib Mesylate","share_pct":20},{"name":"Sprycel","share_pct":13.3}],"max_beneficiaries":null},{"class":"BCL-2 Inhibitor","setting":"prescribed","share_pct":0.6,"drugs":[{"name":"Venclexta","share_pct":100}],"max_beneficiaries":13}]},{"area":"Anti-infectives","share_pct":0.9,"classes_total":1,"classes":[{"class":"Azole Antifungal","setting":"prescribed","share_pct":0.9,"drugs":[{"name":"Posaconazole","share_pct":100}],"max_beneficiaries":13}]}],"care_setting":{"dominant":"office","data_year":2024,"office_pct":93,"facility_pct":7},"source":"medicare"},"publications":{"total":27,"shown":5,"withheld":22,"matched_by":"OpenAlex author record","recent":[{"title":"AI-derived prediction of response and relapse to venetoclax plus hypomethylating agent based therapy in Acute Myeloid Leukemia","year":2025,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2025-1731","status":"verified"},{"title":"Bone marrow microenvironment overlap between vexas and myelodysplastic syndrome demonstrated by targeted transcriptomic and artificial intelligence","year":2025,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2025-5611","status":"verified"},{"title":"IDH1 mutation predicts response and survival in treatment-naïve Acute Myeloid Leukemia patients receiving with venetoclax with a hypomethylating agent","year":2025,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2025-7032","status":"verified"},{"title":"Developing transcriptomic signature for IDH1 and IDH2 acute leukemia and the demonstration of high prevalence of these signatures in mutation-negative leukemia","year":2025,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2025-5251","status":"verified"},{"title":"Developing artificial intelligence-based transcriptomic signature for selecting patients with HOXA-MEIS1 pathway abnormalities for the treatment with menin inhibitors","year":2025,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2025-3471","status":"verified"}],"source":"works"},"contact":{"address_1":"92 2ND ST","city":"Hackensack","state":"NJ","zip":"076012191","phone":"551-996-3925","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1417358367","source":"identity"},"similar":[{"name":"Steven Ghanny","slug":"steven-ghanny","institution":"Hackensack University Medical Center","specialty":"Pediatric Endocrinology","url":"https://www.findmykol.com/kol/steven-ghanny","json_url":"https://www.findmykol.com/kol/steven-ghanny/profile.json"},{"name":"Andre Goy","slug":"andre-goy","institution":"Hackensack University Medical Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/andre-goy","json_url":"https://www.findmykol.com/kol/andre-goy/profile.json"},{"name":"David Vesole","slug":"david-vesole","institution":"Hackensack University Medical Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/david-vesole","json_url":"https://www.findmykol.com/kol/david-vesole/profile.json"},{"name":"Martin Gutierrez","slug":"martin-gutierrez","institution":"Hackensack University Medical Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/martin-gutierrez","json_url":"https://www.findmykol.com/kol/martin-gutierrez/profile.json"},{"name":"Joseph Antin","slug":"joseph-antin","institution":"Harvard University","specialty":"Hematology","url":"https://www.findmykol.com/kol/joseph-antin","json_url":"https://www.findmykol.com/kol/joseph-antin/profile.json"},{"name":"Scott Kaufmann","slug":"scott-kaufmann","institution":"Mayo Clinic College of Medicine","specialty":"Hematology","url":"https://www.findmykol.com/kol/scott-kaufmann","json_url":"https://www.findmykol.com/kol/scott-kaufmann/profile.json"},{"name":"Jeffrey Miller","slug":"jeffrey-miller","institution":"University of Minnesota Medical School","specialty":"Hematology","url":"https://www.findmykol.com/kol/jeffrey-miller","json_url":"https://www.findmykol.com/kol/jeffrey-miller/profile.json"},{"name":"Ruben Mesa","slug":"ruben-mesa","institution":"Atrium Health Wake Forest Baptist Comprehensive Cancer Center","specialty":"Hematology","url":"https://www.findmykol.com/kol/ruben-mesa","json_url":"https://www.findmykol.com/kol/ruben-mesa/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":48,"publications":22}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2022-01-26","provider_certified":"2022-01-26","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}